Axl plays a role in radio-resistant and checkpoint immune-resistant tumours through the suppression of antigen presentation through MHC-I and enhancement of myeloid-supporting cytokines and chemokines leading to an inadequate initial immune response [10,54]. Here, AXL is linked to neoplasm.